Article
Oncology
Jianwei Liu, Guokun Zhuang, Shilei Bai, Zhiliang Hu, Yong Xia, Caixia Lu, Jie Wang, Chunyan Wang, Liu Liu, Fengwei Li, Yeye Wu, Feng Shen, Kui Wang
Summary: This study investigated the impact of surgical margin and hepatic resection on prognosis for patients with hepatocellular carcinoma (HCC). The results showed that for patients with MVI-positive HCC, wide margins and anatomical resection were protective factors for prognosis, with wide margins being more important. In clinical practice, ensuring wide margins should be prioritized.
Article
Surgery
Xin-Fei Xu, Yong-Kang Diao, Yong-Yi Zeng, Chao Li, Feng-Wei Li, Li-Yang Sun, Han Wu, Kong-Ying Lin, Lan-Qing Yao, Ming-Da Wang, Cheng-Wu Zhang, Wan Yee Lau, Feng Shen, Tian Yang
Summary: This study investigated the relationship between the severity in the grading of microvascular invasion (MVI) and long-term oncological outcomes in patients with early-stage hepatocellular carcinoma (HCC). The results showed that the severity in MVI grading was independently associated with recurrence and survival after HCC resection. Patients with a more severe MVI grading (M2) require more stringent recurrence surveillance and/or active adjuvant therapy against recurrence.
INTERNATIONAL JOURNAL OF SURGERY
(2023)
Article
Gastroenterology & Hepatology
Zhen-Hua Chen, Xiu-Ping Zhang, Jin-Kai Feng, Le-Qun Li, Fan Zhang, Yi-Ren Hu, Cheng-Qian Zhong, Jie Shi, Wei-Xing Guo, Meng-Chao Wu, Wan Yee Lau, Shu-Qun Cheng
Summary: One-third of HCC patients with MVI achieved the long-term survival milestone of 5 years after resection. Anatomical hepatectomy, controlling intraoperative blood loss, a wide resection margin, and postoperative adjuvant TACE should be considered to improve long-term survival outcomes.
HEPATOLOGY INTERNATIONAL
(2021)
Article
Oncology
Yafang Zhang, Qingyue Wei, Yini Huang, Zhao Yao, Cuiju Yan, Xuebin Zou, Jing Han, Qing Li, Rushuang Mao, Ying Liao, Lan Cao, Min Lin, Xiaoshuang Zhou, Xiaofeng Tang, Yixin Hu, Lingling Li, Yuanyuan Wang, Jinhua Yu, Jianhua Zhou
Summary: This study developed a deep convolutional neural network model based on contrast-enhanced ultrasound to predict microvascular invasion in hepatocellular carcinoma patients and thus predict prognosis. The CECL-DCNN model showed higher specificity and accuracy in predicting MVI compared to clinical models.
FRONTIERS IN ONCOLOGY
(2022)
Article
Oncology
Jiang-Min Zhou, Chen-Yang Zhou, Xiao-Ping Chen, Zhi-Wei Zhang
Summary: In patients with tumors ranging from 2-5 cm, anatomic resection (AR) can effectively remove peritumoral microvascular invasion (MVI) by obtaining a wide surgical margin, reducing postoperative recurrence, and improving prognosis.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY
(2021)
Article
Gastroenterology & Hepatology
Pinghua Yang, Fei Teng, Shilei Bai, Yong Xia, Zhihao Xie, Zhangjun Cheng, Jun Li, Zhengqing Lei, Kui Wang, Baohua Zhang, Tian Yang, Xuying Wan, Hao Yin, Hao Shen, Timothy M. Pawlik, Wan Yee Lau, Zhiren Fu, Feng Shen
Summary: This study compared the prognosis of hepatocellular carcinoma (HCC) patients undergoing liver resection (LR) and liver transplantation (LT) based on predicted risks of microvascular invasion (MVI). The results showed that LT had better 5-year recurrence rate and 5-year overall survival rate than LR for patients with high or low risk of MVI. However, there was no significant difference in prognosis between LT and LR for patients with low MVI risk.
GASTROENTEROLOGY REPORT
(2023)
Article
Surgery
Wang Yanhan, Lu Lianfang, Liu Hao, Ding Yunfeng, Song Nannan, Lin Fanfan, Zhu Chengzhan, Wu Meilong, Sun Chuandong
Summary: The study analyzed the impact of microvascular invasion (MVI) on the prognosis of hepatocellular carcinoma (HCC) and evaluated the risk factors for MVI, which could aid in decision-making for high-risk recurrence patients.
FRONTIERS IN SURGERY
(2021)
Article
Oncology
Xiang-Pan Meng, Tian-Yu Tang, Zhi-Min Ding, Jitao Wang, Chun-Qiang Lu, Qian Yu, Cong Xia, Tao Zhang, Xueying Long, Wenbo Xiao, Yuan-Cheng Wang, Shenghong Ju
Summary: This study developed two prediction models for microvascular invasion (MVI) in hepatocellular carcinoma (HCC) using clinical factors and preoperative computed tomography images. The models were compared and it was found that the model incorporating radiomics provided a more accurate estimation of MVI. This has the potential to assist in choosing the appropriate surgical procedure for HCC patients.
ANNALS OF SURGICAL ONCOLOGY
(2022)
Article
Gastroenterology & Hepatology
Ji H. Nahm, Hye S. Lee, Haeryoung Kim, Sun Y. Yim, Ji-hyun Shin, Jeong E. Yoo, Sang H. Ahn, Jin S. Choi, Ju-Seog Lee, Young N. Park
Summary: This study developed a nomogram for predicting late recurrence of hepatocellular carcinoma (HCC) based on clinicopathological and molecular factors. The combination of pSTAT3, pERK1/2 and SYK immunoexpression with high lobular inflammatory activity and cirrhosis was found to predict late HCC recurrence.
LIVER INTERNATIONAL
(2021)
Article
Oncology
Tao He, Jieyu Zou, Ke Sun, Juan Yang, Tingting Lei, Lin Xu, Jinheng Liu, Sineng Yin, Guangkuo Li
Summary: Over the past decade, there has been a growing number of studies on microvascular invasion in hepatocellular carcinoma. This study used bibliometric analysis to analyze the literature and summarize the key contributions and future research hotspots in this field.
FRONTIERS IN ONCOLOGY
(2022)
Article
Gastroenterology & Hepatology
Aurelie Beaufrere, Stefano Caruso, Julien Calderaro, Nicolas Pote, Jean-Charles Bijot, Gabielle Couchy, Francois Cauchy, Valerie Vilgrain, Jessica Zucman-Rossi, Valerie Paradis
Summary: With the use of transcriptomic signature, we identified a 6-gene expression signature that is associated with microvascular invasion in hepatocellular carcinoma (HCC). This signature can be applied to routine tumor biopsies and is also associated with overall survival.
JOURNAL OF HEPATOLOGY
(2022)
Article
Oncology
Liuhua Long, Bo Chen, Hongzhi Wang, Yuting Zhao, Fan Wu, Liming Wang, Weiqi Rong, Jianxiong Wu, Yexiong Li, Weihu Wang
Summary: This study evaluated the effects of postoperative radiotherapy (PORT) on prognosis and recurrence in patients with hepatocellular carcinoma (HCC) who underwent narrow-margin hepatectomy (NH). The results showed that the PORT group had significantly higher 5-year overall survival and disease-free survival rates compared to the non-PORT group, and the tumor recurrence rate was lower in the PORT group. Therefore, postoperative radiotherapy may have significant benefits in the treatment of HCC.
RADIOTHERAPY AND ONCOLOGY
(2023)
Article
Surgery
Xiu-Ping Zhang, Shuai Xu, Zhao-Yi Lin, Qing-Lun Gao, Kang Wang, Zi-Li Chen, Mao-Lin Yan, Fan Zhang, Yu-Fu Tang, Zhi-Ming Zhao, Cheng-Gang Li, Wan Yee Lau, Shu-Qun Cheng, Ming-Gen Hu, Rong Liu
Summary: This study aimed to evaluate the impact of anatomical resection (AR) versus nonanatomical resection (NAR) combined with resection margin (RM) on long-term prognosis in HCC patients with MVI. The results showed that AR combined with wide RM can significantly improve overall and recurrence-free survival rates for these patients.
INTERNATIONAL JOURNAL OF SURGERY
(2023)
Article
Medicine, General & Internal
Kai Zhang, Changcheng Tao, Fan Wu, Tana Siqin, Jianxiong Wu, Weiqi Rong
Summary: The study identified MVI grouping, preoperative serum AFP, number of tumors, satellite nodules, hepatic capsule invasion, tumor diameter, and lymph node metastasis as independent risk factors for early postoperative recurrence of hepatocellular carcinoma in patients with microvascular invasion. Through these factors, a predictive model was developed with good performance in predicting early recurrence.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE
(2021)
Article
Oncology
Lihong Liu, Yongjie Shui, Qianqian Yu, Yinglu Guo, Lili Zhang, Xiaofeng Zhou, Risheng Yu, Jianying Lou, Shumei Wei, Qichun Wei
Summary: Patients with narrow resection margin had higher recurrence rate and worse survival compared to those with wide resection margin. Adjuvant local treatment, such as radiotherapy, may benefit these patients. Postoperative SBRT for cases with positive margin showed low recurrence rate and no marginal recurrence.
FRONTIERS IN ONCOLOGY
(2021)